Expressive Communication Technologies for People with ALS episode artwork

EPISODE · Jul 10, 2017 · 1H 2M

Expressive Communication Technologies for People with ALS

from NYUAD Institute · host NYUAD Institute

April 20, 2017 ALS (amyotrophic lateral sclerosis) is a degenerative neuromuscular disease; people with late-stage ALS typically retain cognitive function, but lose the motor ability to speak, relying on gaze-controlled AAC (augmentative and alternative communication) devices for interpersonal interactions. State-of-the-art AAC technologies used by people with ALS do not facilitate natural communication; gaze-based AAC communication is extremely slow, and the resulting synthesized speech is flat and robotic. This lecture presents a series of novel technology prototypes from the Microsoft Research Enable team that aim to address the challenges of improving the expressivity of AAC for people with ALS. Meredith Ringel Morris Computer Scientist and Principal Researcher, Microsoft Research

April 20, 2017 ALS (amyotrophic lateral sclerosis) is a degenerative neuromuscular disease; people with late-stage ALS typically retain cognitive function, but lose the motor ability to speak, relying on gaze-controlled AAC (augmentative and alternative communication) devices for interpersonal interactions. State-of-the-art AAC technologies used by people with ALS do not facilitate natural communication; gaze-based AAC communication is extremely slow, and the resulting synthesized speech is flat and robotic. This lecture presents a series of novel technology prototypes from the Microsoft Research Enable team that aim to address the challenges of improving the expressivity of AAC for people with ALS. Meredith Ringel Morris Computer Scientist and Principal Researcher, Microsoft Research

NOW PLAYING

Expressive Communication Technologies for People with ALS

0:00 1:02:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of NYUAD Institute?

This episode is 1 hour and 2 minutes long.

When was this NYUAD Institute episode published?

This episode was published on July 10, 2017.

What is this episode about?

April 20, 2017 ALS (amyotrophic lateral sclerosis) is a degenerative neuromuscular disease; people with late-stage ALS typically retain cognitive function, but lose the motor ability to speak, relying on gaze-controlled AAC (augmentative and...

Can I download this NYUAD Institute episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!